Amedisys Inc
NASDAQ:AMED
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
83.78
98.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Amedisys Inc
Amedisys Inc
Cost of Revenue
Amedisys Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Cost of Revenue
-$1.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$316.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$206.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$9.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
|
|
R1 RCM Inc
NASDAQ:RCM
|
Cost of Revenue
-$2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-27%
|
|
Amedisys Inc
Glance View
Amedisys Inc., headquartered in Baton Rouge, Louisiana, has crafted its narrative at the forefront of America's healthcare sector, by focusing squarely on providing quality home health and hospice services. Established in 1982, the company has steadily expanded its reach, now operating in more than 30 states with a strong network of healthcare professionals dedicated to delivering comprehensive care at the patient's doorstep. Amedisys identifies the growing preference for home-based care among patients and leverages this trend by offering services in home health, hospice, and personal care. This strategic focus aligns with the nationwide shift towards value-based care, where healthcare providers are rewarded for the quality and effectiveness of care given to patients rather than volume. The company's financial engine thrives on two primary service lines: home health and hospice care. Home health services are Amedisys’s backbone, generating revenue by providing skilled medical care and support services at home to patients recovering from illnesses, surgeries, or those managing chronic diseases. Their clinicians, comprising nurses and therapists, work closely with patients to ensure a personalized care plan tailored to individual needs. Hospice care, on the other hand, caters to terminally ill patients, offering support that prioritizes comfort and quality of life in their final days. By understanding the intricacies of Medicare, Medicaid, and private insurance billing, Amedisys efficiently navigates reimbursement pathways, ensuring steady cash flow while aligning with regulatory requirements. This operational model not only feeds into Amedisys's financial health but also solidifies its role as a crucial player in the evolving landscape of at-home healthcare services.
See Also
What is Amedisys Inc's Cost of Revenue?
Cost of Revenue
-1.3B
USD
Based on the financial report for Sep 30, 2024, Amedisys Inc's Cost of Revenue amounts to -1.3B USD.
What is Amedisys Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-6%
Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Amedisys Inc have been -3% over the past three years , -3% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet